Found 10 matching trials
Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate
PHASE2RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and ei...
Location
Memorial Sloan-Kettering Cancer Center
177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC
PHASE1Phase I dose escalation study with combination of 177Lu-J591 and 177Lu-PSMA...
Location
Weill Cornell Medical College
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
PHASE1The purpose of this study is to evaluate changes in tumor blood flow and di...
Location
Weill Cornell Medical College
Re-treatment 225Ac-J591 for mCRPC
EARLY_PHASE1The purpose of this study is to find out if re-treatment with 225Ac-J591 ca...
Location
Brooklyn Methodist Hospital - New York Presbyterian
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
PHASE2The purpose of this study is to test the effectiveness of the experimental ...
Status
Active Not Recruiting
Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer
PHASE1The purpose of this study is to test the effectiveness of the experimental ...
Location
Weill Cornell Medical College
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
PHASE1This is a phase I dose-escalation study of 225Ac-J591 administered together...
Location
Brooklyn Methodist Hospital - New York Presbyterian
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC
PHASE1The purpose of the initial (phase I) portion of this study is to find a dos...
Status
Active Not Recruiting
Location
Brooklyn Methodist Hospital - New York Presbyterian
Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody
PHASE1The purpose of this study is to test the safety of the experimental drug, 1...
Location
Weill Cornell Medical College-New York Presbyterian Hospital
Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer
PHASE2The purpose of this study is to find out how effective 177Lu -J591 is in th...
Location
Weill Medcial College of Cornell University